Table 2.
General results
| Admission (8.6%) | Topographical diagnosis | Aetiological diagnosis (toast) 10 | Clinical presentation | US Stenosis | Holter | TTE/TEE | Treat |
|---|---|---|---|---|---|---|---|
| Persistence of clinical signs and symptoms 1 |
Left H. 42% |
Cardioembolic 47% |
Dysphasia 13% Monoparesis 11.2% |
BA 4.3% |
AF 36 |
Atypical akinesia 5 |
LMWH 53.5% |
| Clinical instability due to comorbidity 3 |
Right H. 23% |
Cryptogenic 35% |
Facial paresis 8.1% |
ICA 3.7% |
AT 2 |
PFO 4 |
ASA 29.2% |
| Symptomatic cervical stenosis 6 |
V-B 18% |
Atherothrombotic 7% |
Dysarthria 8.1% Hemiparesis 6.2% |
VA 3.1% |
advanced AVB 2 |
Severe MI with dilated LA 2 |
clopidogrel 9.6% |
| Symptomatic intracranial stenosis 3 |
Imprecise 17% |
Lacunar 5% |
Ataxia 3.1% Diplopia 1.8% Hemianopsia 0.6% |
MCA 1.8% |
ABV-II 2 USVT 2 |
EF < 30% 1 |
triflusal 7.7% statins 10% |
| |
|
Undetermined due to several causes 5% |
|
ACA 1.2% |
Severe pause 1 |
IAC 1 |
ACEI 1.2% ARA-II 2.5% |
| PCA 0.6% | AF 1 |
[10]: Number of reference of TOAST classification in the manuscript.